MxBiodevices, a nano scaffold provider, specializes in E-Matrix treatments for chronic wounds and ulcers.
Founded in August 2009, MxBiodevices focuses on commercializing an injectable nano scaffold, E-Matrix, designed for the treatment of diabetic foot ulcers (DFUs) and other chronic wounds. The company's core mission is to revolutionize wound care through advanced nanotechnology, improving patient outcomes and reducing healthcare costs. MxBiodevices offers a range of E-Matrix products that have found success in orthopedics and spine treatments, and they hold an exclusive license for E-Matrix applications in chronic wound care.
The founders of MxBiodevices have been pivotal in the development of E-Matrix over the past decade, leading to six commercially successful products. Key achievements include securing the exclusive license for E-Matrix in chronic wound treatment in February 2012. The company's innovative approach has significantly impacted the medical field, providing effective solutions for difficult-to-treat conditions like DFUs and decubitus ulcers.

Imbed Biosciences
imbedbio.com

Biofisica
biofisica.com

MLM Biologics
mlmbiologics.com

NeXtGen Biologics

Medtric
medtricbiotech.com

Noxsano
noxsano.com

Endomimetics
endomimetics.com

MDM Wound Ventures
ezdebride.com

Reprise Biomedical
reprisebio.com

Molecular Matrix

Nanosonic
nanosonic.com

Ulcer Solutions
ulcersolutions.com
MHB Labs
mhblabs.com

BioNova
bionovamedical.com

SweetBio
sweetbio.com

MatrixMed
matrixmed.co

BioNanovations

MJ3 Industries
mj3industries.com

MBX Biosciences
mbxbio.com

Orthobond
orthobond.com
MxBiodevices' most recent funding round was for $210k (USD) in February 2014.
As of Feb 10, 2014, MxBiodevices has disclosed funding of $210k (USD).